Port of Corpus Christi Authority and Stabilis Solutions Partner to Construct LNG Fueling Infrastructure for Marine Vessels
04 mai 2021 15h13 HE
|
Stabilis Solutions
HOUSTON, TX, May 04, 2021 (GLOBE NEWSWIRE) -- The Port of Corpus Christi Authority and Stabilis Solutions Inc. (“Stabilis”) (NASDAQ:SLNG), a leading provider of energy transition services,...
Ocera Announces Successful Phase 1 Clinical Study of Orally-Administered OCR-002 in Patients with Cirrhosis
05 janv. 2017 09h05 HE
|
Ocera Therapeutics, Inc.
Data Support Feasibility of Oral OCR-002 as Maintenance Therapy for Patients with Hepatic Encephalopathy Company Plans to Initiate Phase 2a in H1 2017 with New Optimized Tablet Formulation PALO...
Ocera to Present at the Ladenburg Thalmann 2nd Annual Healthcare Conference
20 sept. 2016 09h10 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and...
Ocera Announces Positive Phase 1 Results for Oral OCR-002 in Development for the Prevention of Chronic Hepatic Encephalopathy
16 nov. 2015 16h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Nov. 16, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and...